Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Icosavax, Inc.
  6. News
  7. Summary
    ICVX   US45114M1099

ICOSAVAX, INC.

(ICVX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Icosavax, Inc.(NasdaqGS:ICVX) added to S&P TMI Index

09/20/2021 | 12:00am EST

Icosavax, Inc.(NasdaqGS:ICVX) added to S&P TMI Index


ę S&P Capital IQ 2021
All news about ICOSAVAX, INC.
11/18ICOSAVAX, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
11/15ICOSAVAX, INC. Management's Discussion and Analysis of Financial Condition and Results..
AQ
11/15ICOSAVAX : Reports Third Quarter 2021 Financial Results and Provides Corporate Update - Fo..
PU
11/15Earnings Flash (ICVX) ICOSAVAX Posts Q3 Loss $-1.30
MT
11/15Icosavax Reports Third Quarter 2021 Financial Results and Provides Corporate Update
GL
11/15Icosavax Reports Third Quarter 2021 Financial Results and Provides Corporate Update
GL
11/11Icosavax to Participate in Upcoming Investor Conferences
GL
11/11Icosavax to Participate in Upcoming Investor Conferences
GL
09/20ICOSAVAX, INC.(NASDAQGS : ICVX) added to S&P TMI Index
CI
09/13ICOSAVAX : Management's Discussion and Analysis of Financial Condition and Results of Oper..
AQ
More news
Analyst Recommendations on ICOSAVAX, INC.
More recommendations
Financials (USD)
Sales 2021 6,93 M - -
Net income 2021 -66,7 M - -
Net Debt 2021 - - -
P/E ratio 2021 -8,18x
Yield 2021 -
Capitalization 1 076 M 1 076 M -
Capi. / Sales 2021 155x
Capi. / Sales 2022 860x
Nbr of Employees 28
Free-Float 69,8%
Chart ICOSAVAX, INC.
Duration : Period :
Icosavax, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ICOSAVAX, INC.
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 27,55 $
Average target price 48,57 $
Spread / Average Target 76,3%
EPS Revisions
Managers and Directors
Adam K. Simpson President, Chief Executive Officer & Director
Thomas J. Russo Chief Financial Officer
Douglas Holtzman Chief Scientific Officer
Niranjan Kanesa-thasan Chief Medical Officer
Charles E. Richardson Senior Vice President-Technical Operations
Sector and Competitors
1st jan.Capi. (M$)
ICOSAVAX, INC.0.00%1 076
MODERNA, INC.215.53%133 648
LONZA GROUP AG29.85%59 443
IQVIA HOLDINGS INC.46.26%50 064
SEAGEN INC.-3.22%30 994
CELLTRION, INC.-40.39%24 431